1/330
Looks like no tags are added yet.
cancer lifetime risk
50%
new cancers annually in US
2 million
3.5 million including non-melanoma skin cancer
cause of death ranking in us
#2
some states and canada = #1
cause of death ranking for children 1-14
#2 (after accidents)
number in the us who have/had cancer
18 million
external causes of cancer
tobacco
infectious agents
chemicals
radiation
internal causes of cancer
inherited mutations (~5% all cancers)
spontaneous mutations
clocklike mutations
fold increase in lung cancer risk with tobacco use
>20x
top 3 cancers by incidence WOMEN
1: breast
2: lung/bronchus
3: colon/rectum
top 3 cancers by incidence MEN
1: prostate
2: lung/bronchus
3: colon/rectum
top 3 cancers by death WOMEN
1: lung/bronchus
2: breast
3: pancreas
top 3 cancers by death MEN
1: lung/bronchus
2: prostate
3: colon/rectum
1992 male incidence peak cause
prostate cancer overdiagnosis
new test for prostate cancer; measures PSA (prostate specific antigen). more psa in blood = larger prostate (indicative of cancer)
BUT as you age, prostate naturally grows, so older men naturally have higher PSA even if no cancer
number of cancer deaths averted 1991 to 2023 MEN
3,256,800
number of cancer deaths averted from 1992 to 2023 WOMEN
1,555,300
breast cancer peak in 1980s and 90s
over-diagnosis
introduction of mammograms
detection of lumps that turned out to be entirely benign and natural as women age
cause of stomach cancer reduction
refrigeration means have fresh food
oxidation of food is bad
why was lung cancer peak later for women
women started smoking more during WW2
male cancer risk difference; why
20% higher than females
much is sex specific behaviors (more likely to do risky activities more [smoke, drink]), can’t explain it all though
genetic mechanism for higher risk in men
double hit hypothesis
6 tumor supressors are expressed on both X chromosomes (part of Xi that is actually expressed); second X can show tumor suppressing genes and it’s harder to hit two mutations than 1
men only have one X chromosome, so only need a single mutation to cause cancer
liver cancer incidence in developing/developed countries
higher in developing
not controversial (more drinking)
prostate cancer incidence in developing/developed countries
higher in developed
more controversial (typically longer life expectancy in developed countries and prostate cancer happens later in life)
cervix cancer incidence in developing/developed countries
higher in developing
higher rates of HPV infection
esophagus cancer incidence in developing/developed countries
higher in developing
drinking
japanese migrant study
japanese males: high stomach/liver death rates, low colon/prostate
japanese immigrants: lower stomach/liver, higher colon/prostate
sons of immigrants: lower stomach/liver, higher colon/prostate
cali whites: equal levels stomach, liver, colon, prostate
[compare each to one above; each generation more similar to cali levels]
geographic differences in bladder cancer causes
asian: artistolochic acid (wheat flour contamination, traditional asian medicines)
europe: mixed mutagens (balkans region = aristolochic acid)
aristolochic acid
toxic chemical in weeds/plants
geographic differences in causes of kidney cancer
all countries: tobacco signature, obesity (risk factor but no mutation signature)
balkans, south asia: aristolochic acid (wheat flour, traditional medicines)
japan: 70% have japanese specific mutagenic signature of unknown carcinogen
northern europe, canada, us, uk: signature of different unknown carcinogen
geographic differences in liver cancer causes
china (~50% all liver cancers worldwide): aristolochic acid, aflatoxin b, unknown carcinogen, HBV/HCV viruses
europe: not any of those!
aflatoxin b
toxin produced by fungus, grown on corn and nuts
neoplasms
“new growth”
adenoma
benign tumor
carcinoma
~85% cancers
malignant tumors derived from epithelial cells
adenocarcinoma
epithelium, secretory functions
ex: prostate
squamous cell carcinoma
from epithelial cells forming protective layers
ex: skin
leukemia
transformed cells from bone marrow
lymphoma
cancer of lymph node or spleen
sarcoma
malignant tumors of cells that are mesothelial (mucosal, fibroblast) in origin
ex: osteosarcoma
major groups of tissues
mesenchyme
epithelial
reticuloendothelial
nervous
mesenchyme tissue
general supportive tissues
fibroblasts, connective tissue, muscle
epithelial tissue
tissue specific cells
keratinocytes
reticuloendothelial
most derive from bone marrow
lymphocytes, erythrocytes, endothelial
benign tumor differentiation
well differentiated
typical of tissue of origin
benign tumor growth
usually slow
benign tumor local invasions
well demarcated mass
no invasions/infiltrations
benign tumors metastasis
absent
malignant tumor differentiation
some lack differentiation
structure is often atypical
malignant tumor growth
erratic, slow to rapid
malignant tumor local invasions
always invasive; infiltrates surrounding normal tissue
malignant tumor metastasis
frequent
cell progression from normal to metastatic
normal cell → benign cell → invasive tumor → metastatic tumor
principal cause of cancer
mutations in growth controlling genes
1 oncogene or 2 tumor suppressors
molecular causes of cancer: epigenetic changes
changes in gene expression
DNA methylation, chromatin remodeling, miRNA
carcinogenicity testing history
1915: painting coal tar on rabbit ears causes skin cancer
1971: developed principles of carcinogenicity testing
1971 FDA/NCI carcinogenicity testing; negatives
2 species, 2 sexes, 2 years, 2 doses (max tolerated dose and 0.5 MTD)
cons: expensive. ~10$ million per chemical for this testing
genotoxicity assays
chromosomal damage, activation of DNA repair, detection of specific DNA lesion
EPA approximation of risk increase for early childhood exposures
~10x higher
children with mutations have much longer time for mutations to grow
damage ≠ mutation (different damage has different probability of converting to mutation)
carcinogenic process
exogenous + endogenous factors → DNA damage → mutations → malignant cell
exogenous carcinogens
genotoxic chemicals, physical carcinogens, viruses (diff mxn; mess with suppression not damaging DNA)
endogenous carcinogens
endogenous mutagens, spontaneous DNA changes, replication errors, rMNPs in DNA, dietary factors/metabolism
types of carcinogens
tumor initiator (need to be paired with promoter)
tumor promoter (need to be paired with initiator)
complete carcinogen (both initiator and promoter; easy to detect)
tumor promoter examples
phorbol esters, penobarbital
tumor initiator mxn
DNA damage → mutations
tumor promoter mxn
increased proliferation
pro-carcinogen vs carcinogen
pro-carcinogens require bioactivation (~75% carcinogens)
xenobiotics
hydrophobic, need to be hydrophilic to excrete
xenobiotic biotransformation purpose
lower biological half life (retention)
change biological activity
xenobiotic biotransformation phase I rxn
reduction, oxidation, hydrolysis rxns
introduction of reactive groups [active group can cause other problems]
often cytochrome p-450
xenobiotic biotransformation phase II rxn
conjugation rxns with hydrophilic molecules (sulfate, glucaronic acid, glutathione)
hydrophilic and more exretable
xenobiotic biotransformation phase balance
want phase 1 and phase 2 balance
eg if 1 is too fast and 2 is slow → DNA damage
aflatoxin-N7dG-DNA adduct
stalls DNA pol
can be result of metabolism of aflatoxin B1
main causes of lung cancer in us
1: smoking tobacco
non-smokers (20-25% lung cancers; higher % asian and women)
1: air pollution (PM2.5 [particulate matter <2.5micro m
gets stuck in lungs; larger particles get stuck and can be coughed out
2: radon
*passive smoking/2nd hand smoking has no extra risks from mutation signatures
part could be that there is no significantly less 2nd hand smoke exposure
other cancers attributable to tobacco smoking
oropharynx, larynx, esophagus
carcinogens in tobacco
>20 known carcinogens total
PAH (polycyclic aromatic hydrocarbons): bioactivated by CYP450
benzo[a]pyrene → benzo[a]pyrene diol epoxide
nitrosamines [DNA methylation and other adducts]: bioactivation by CYP450
formaldehyde/other carbonyls: directly reactive with DNA
nicotine and nitrosoderivatives (non mutagenic activity)
tumor initiator tobacco carcinogens
PAHs, nitrosamines, aldehydes
tumor promoter tobacco carcinogens
nicotine (via acetylcholine receptors)
preventable cancer estimates
50-80% preventable
extrinsic causes of lung cancer
tobacco smoking, air pollution, radon exposure
extrinsic causes of liver cancer
viruses (hep B/C), aflatoxin B, alcohol
extrinsic causes of cervical cancer
HPV (human papillomaviruses)
extrinsic causes of skin cancer
UV light
extrinsic causes of stomach cancer
helicobacter pylori
extrinsic causes of colon cancer
diet
mxn of obesity in cancer risk
type 2 diabetes (high insulin = high growth factor for colon cancers; cancer cells like high glucose)
immunosupression/proinflamamatory state (promotes growth of initiated cells)
acid reflux is carcinogenic for esophagus
study design for chemopreventive agents
mouse → carcinogen, control or chemopreventive agent in diet (latency period), tumor burden
problems: relevant carcinogen, timing of intervention, nonhuman model
malignant transformation of cells
(mutagens, mutations) → initiation → (promotors, expansion of initiated cells) → promotion → (more mutations, benign to malignant) → progression
antioxidants
could be protective in initiation → promotion stage
could cause more aggressive cancer in promotion → progression stage
cells have oxidative stress, relieving oxidative stress means more proliferation
transmissible cancers
facial tumors in tasmanian devils
melanoma in brown bullhead catfish
parasitic leukemia in soft-shell clams
canine transmissble venereal tumor/sarcoma
leukemia in lab rodents
human transmissible infections
donor organs/tissues (most commonly melanoma)
mother to child in utero
between twins in utero
(in utero is leukemia)
facial tumors in tasmanian devils
spread by attacking/scratching/biting
tumors from different animals were sequenced and they were the same (shows from the same original)
DFT1
devil facial tumor 1
originated in 1986 in female devils
most common, infects both sexes
no MHC-I (no way of knowing cells shouldn’t be there)
DFT2
devil facial tumor 2
originated in 2011, in male devil
infects primarily males
abnormal MHC-I
melanoma in brown bullhead catfish
jumps from one fish to another
happens around age 3 when they start sexual relations
parasitic leukemia in soft-shell clams
clams have extended siphons; leukemia spreads between
similar leukemia in mussels and oysters
found because:
normal clams, hemocyte genotypes match individual genotypes
leukemic claims, neoplastic hemocyte genotypes are nearly identical and do not match host genotypes
canine transmissible venereal tumor/sarcoma
most common cancer in dogs, usually cleared in 3-4 months (non lethal)
~8000 years ago in East Siberia
responsible for the disappearance of pre-European American dogs (genetically ~ ancestral East SIberian dogs)
lab rodents transmissible cancer
leukemia in Syrian hamsters via mosquito’s bites
clonal origin of non-viral cancer
monoclonal
evidence for clonal origin in humans
X-linked polymorphism in G6PD isoenzymes A and B
In females, random choice of X chromosome active in every cell
Normal tissues are polyclonal (both isoenzymes)
Tumors are monoclonal (one isoenzyme)
ways to test cells for acquisition of transformation
in tissue culture: loss of contact/density inhibition (cancer cells can grow on top of each other), loss of anchorage-dependence (cancer cells don’t need agar)
ability to form tumors in vivo
8 hallmarks of cancer
SILENT ME
Self-sufficiency with growth signaling
Insensitivity to growth inhibition
Limitless replication potential
Evasion of apoptosis
Neo-angiogenesis
Tissue invasion and metastasis
Metabolic reprogramming
Evasion of immune system